About Julian Mittleman Fundraiser

In December 2022, our Julian aka “Juju” was diagnosed with Stage 4 Neuroblastoma. The shock of his diagnosis hit us hard but our family quickly sprung into action and we immediately started treatment.  

He comes from a long line of courageous, brave and strong-minded people and has been handling his new normal like a champion. He has shown our entire family what a true warrior looks like and we know he has the strength and determination to conquer his diagnosis. 

Juju loves nothing more than playing his “row rows” (guitars), listening to music, singing songs and entertaining his little sister, Mila, and his entire family. 

Julian is extremely lucky and blessed despite his diagnosis. He is constantly surrounded by family, friends and has a large community cheering him on. 

Our family would like to raise money for other families that need help. We want to ensure that no other child or family has to go through the same battle Julian is fighting. 

By donating to Band of Parents, you are helping raise awareness and funding for a non-profit organization focused on funding innovative research, clinical trials and less toxic treatments to cure neuroblastoma and keep children in remission longer.

We love you all and can’t thank you enough for all of your support. 

Date

Starts at:  January 12, 2023 11:00 PM
Ends at:  January 12, 2024 11:00 PM

Location

,

Contact

Here is a great spot to put the most important information about your campaign! 


TIP: Did you know you can also add a pre-recorded or live stream video to this section? Just provide the full iframe code in the admin view under Configure Campaign > Design > Basic Design.


TIP: You can inline edit different areas to customize your campaign! Don't forget to save & refresh!

How Your Support Makes A Difference

With your support, we can find a cure for neuroblastoma, while reducing the highly toxic nature of treatment. One day, we hope antibodies will replace chemotherapy.
Band of Parents is the top independent backer of neuroblastoma research at Memorial Sloan-Kettering Cancer Center (MSKCC). Our mission is to seek projects that have already been examined in the lab and are in need of assistance to rapidly move into a patient population. In the 1980s, fewer than 5% of children diagnosed with high risk neuroblastoma survived. Although today, most major medical centers like MSKCC have over a 50% survival rate, far too many children are still dying of this disease. The sad fact is that due to the high cost of research and the small number of children diagnosed annually, pediatric cancer is severely underfunded by both the pharmaceutical industry and the federal government. Less than 4% of the National Cancer Institute’s funding goes to fight pediatric cancer. We support our members through their children’s battle with neuroblastoma. Together, we are Bound by Hope that a cure is out there. We will continue this fight until not a single child is lost to this disease.



Thank you for your support!